Just as generic drugs have dramatically lowered the price of some common medicines and expanded access to them, so follow-on versions of complex biologic drugs to treat diseases like cancer and multiple sclerosis could benefit patients and reduce costs.
NIBR scientists do mini-sabbaticals with clinical researchers at other sites. Learn how they refresh their skills and boost scientific research.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.